Year-End Report — ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP (2007)

Firm

ASTRAZENECA PHARMACEUTICALS LP

Client

ASTRAZENECA PHARMACEUTICALS LP

Income

—

Expenses

$1,700,000

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Proposed increase in Medicaid Drug Rebate drug base rebate increase Proposed changes to Medicaid price reporting and requirements from earlier legislation (DRA) Medicare Part D formulary protection for six specified classes

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
ANDRES IZQUIERDO	N/A
DEANA MCRAE	—
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Consumer Issues/Safety/Products CSP

Patient safety from the commercial importation of prescription medications Manufacturer outsourcing of active pharmaceutical ingredients to certain countries

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
ANDRES IZQUIERDO	N/A
DEANA MCRAE	—
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Illegal compounding of commercially available pharmaceuticals by pharmacists

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
ANDRES IZQUIERDO	N/A
DEANA MCRAE	—
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Renewal of Research and Development Tax Credit within context of proposed changes to Alternative Minimum Tax

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
ANDRES IZQUIERDO	N/A
DEANA MCRAE	—
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S.1145/1908 The Patent Reform Act of 2007 - Potential implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
ANDRES IZQUIERDO	N/A
DEANA MCRAE	—
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1145 (110th)

Health Issues HCR

S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
ANDRES IZQUIERDO	N/A
DEANA MCRAE	—
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3610 (110th), H.R. 3161 (110th), S. 1082 (110th), S. 1859 (110th), H.R. 2900 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.